|Who Needs Hepatitis B Serologic Testing before or after Vaccination?|
|Published November 2016|
|Information presented in this article may have changed since the original publication date. For the most current immunization recommendations from the Advisory Committee on Immunization Practices, visit www.immunize.org/acip/acip_vax.asp.|
|In the August and October Technically Speaking columns, I reviewed CDC’s recommendations for hepatitis B vaccination of infants, children, and teens, as well as adults.
Pre- and/or post-vaccination serologic testing is recommended for some people who are candidates for vaccination.
Pre-vaccination serologic testing
Pre-vaccination testing should be considered for people who are at high risk for past or current hepatitis B virus (HBV) infection who would not benefit from hepatitis B vaccine if found to be currently infected or already immune.
CDC recommends pre-vaccination testing for the following groups:
In addition, testing might be cost effective in populations with a prevalence of HBV infection of 20 percent or higher.
Consult the ACIP recommendations below for details about populations at risk and which tests should be ordered. People with chronic HBV infection should be promptly referred to someone experienced in the management of chronic infection.
Note: Serologic testing should not be a barrier to vaccination, and both can be undertaken during a single office visit. The first vaccine dose should be administered after collection of the blood sample for serologic testing. Vaccinating a person who is infected or immune will do no harm.
Post-vaccination serologic testing
Post-vaccination testing is recommended for people whose subsequent clinical management depends on knowledge of their immune status, and includes the following groups: